CX Institutional’s Hormel Foods HRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383K Buy
15,420
+3,584
+30% +$79.7K 0.01% 541
2026
Q1
$268K Buy
11,836
+128
+1% +$3.06K 0.01% 643
2025
Q4
$277K Buy
11,708
+1,898
+19% +$44.3K 0.01% 606
2025
Q3
$243K Buy
9,810
+2,096
+27% +$58.1K 0.01% 631
2025
Q2
$233K Buy
7,714
+575
+8% +$17.3K 0.01% 575
2025
Q1
$221K Buy
+7,139
New +$212K 0.01% 571
2022
Q3
Sell
-1,735
Closed -$82K 768
2022
Q2
$82K Buy
+1,735
New +$86.6K 0.01% 578
2021
Q4
Sell
-1,173
Closed -$48K 594
2021
Q3
$48K Buy
1,173
+32
+3% +$1.44K ﹤0.01% 587
2021
Q2
$54K Sell
1,141
-116
-9% -$5.52K ﹤0.01% 553
2021
Q1
$60K Buy
1,257
+571
+83% +$27K 0.01% 454
2020
Q4
$32K Buy
686
+229
+50% +$11.2K ﹤0.01% 519
2020
Q3
$22K Buy
457
+62
+16% +$3.11K ﹤0.01% 526
2020
Q2
$19K Buy
395
+221
+127% +$10.6K ﹤0.01% 446
2020
Q1
$8K Sell
174
-6
-3% -$273 ﹤0.01% 481
2019
Q4
$8K Buy
180
+25
+16% +$1.08K ﹤0.01% 464
2019
Q3
$7K Buy
155
+11
+8% +$462 ﹤0.01% 515
2019
Q2
$6K Buy
144
+21
+17% +$852 ﹤0.01% 576
2019
Q1
$6K Buy
+123
New +$5.27K ﹤0.01% 521

Other funds holding HRL

CX Institutional's HRL Position: Q2 2026 in Review

CX Institutional increased its Hormel Foods (HRL) stake by 30% in Q2 2026, buying an estimated $79.7K and bringing the position to 15,420 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #541.

CX Institutional first reported a position in HRL in Q1 2019 and has held it in 18 quarters since. 72 funds tracked by Wall St. Rank hold HRL as of Q2 2026.

  • CX Institutional held 15,420 shares of Hormel Foods worth $383K as of Q2 2026.
  • CX Institutional bought 3,584 Hormel Foods shares in Q2 2026, an estimated $79.7K.
  • Hormel Foods made up 0.01% of CX Institutional's portfolio in Q2 2026, its #541 holding.
  • CX Institutional first reported a position in Hormel Foods in Q1 2019 and has held it in 18 quarters since.
  • 72 funds tracked by Wall St. Rank held Hormel Foods as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.